Short-term stake in Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) increases 56.3%

0

Fresenius Medical Care AG & Co. KGaA (NYSE: FMS – Get a rating) was the target of strong short-term interest growth in June. As of June 30, there was short interest totaling 1,410,000 shares, a growth of 56.3% from the total of 902,000 shares as of June 15. Based on an average daily trading volume of 565,100 shares, the day-to-cover ratio is currently 2.5 days.

A Wall Street analyst gives his opinion

FMS has been the subject of several research analyst reports. Jefferies Financial Group upgraded Fresenius Medical Care AG & Co. KGaA from an “underperforming” rating to a “buy” rating and raised its price target for the company from $30.30 to $33.70 in a report from Monday, June 27. StockNews.com upgraded Fresenius Medical Care AG & Co. KGaA from a “strong buy” rating to a “buy” rating in a report on Friday. JPMorgan Chase & Co. raised its price target on Fresenius Medical Care AG & Co. KGaA from €48.70 ($48.70) to €51.00 ($51.00) and assigned the company a rating “underweight” in a Thursday, May 5, report. Finally, Truist Financial lowered its price target on Fresenius Medical Care AG & Co. KGaA from $34.00 to $27.00 and set a “holding” rating for the company in a Wednesday, June 22 report. One financial analyst gave the stock a sell rating, six gave the stock a hold rating and five gave the stock a buy rating. According to MarketBeat.com, Fresenius Medical Care AG & Co. KGaA currently has an average rating of “Hold” and an average target price of $52.51.

Fresenius Medical Care AG & Co. KGaA trades up 3.0%

A d Invest daily

27 US cities where stocks earn 26% a year

What is the most productive stock you have ever owned? Dividends from these stocks have grown so rapidly over the years that they now earn us an average of 26%! When you start getting paid 26% on your money, your financial troubles tend to evaporate.

FMS was up $0.69 during Friday trading hours, hitting $23.46. 883,722 shares of the company were traded, compared to its average volume of 860,964. Fresenius Medical Care AG & Co. KGaA has a 52-week low of $22.14 and a 52-week high of $41.38 . The company has a 50-day moving average price of $27.10 and a 200-day moving average price of $30.85. The company has a market capitalization of $13.75 billion, a PE ratio of 13.41, a PEG ratio of 0.94 and a beta of 1.21. The company has a quick ratio of 0.93, a current ratio of 1.26 and a leverage ratio of 0.51.

Fresenius Medical Care AG & Co. KGaA (NYSE: FMS – Get a rating) last reported quarterly earnings data on Wednesday, May 4. The company reported earnings per share (EPS) of $0.38 for the quarter, beating the consensus estimate of $0.30 by $0.08. The company posted revenue of $5.10 billion for the quarter, versus $4.97 billion expected by analysts. Fresenius Medical Care AG & Co. KGaA achieved a return on equity of 6.99% and a net margin of 4.91%. As a group, sell-side analysts expect Fresenius Medical Care AG & Co. KGaA to post EPS of 1.98 for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA reduces its dividend

The company also recently disclosed an annual dividend, which was paid on Friday, May 27. Shareholders of record on Monday, May 16 received a dividend of $0.7093. This represents a dividend yield of 3.4%. The ex-dividend date was Friday, May 13. The payout ratio of Fresenius Medical Care AG & Co. KGaA is currently 28.00%.

Institutional trading of Fresenius Medical Care AG & Co. KGaA

Several hedge funds have recently changed their stock holdings. Commonwealth Equity Services LLC increased its stake in Fresenius Medical Care AG & Co. KGaA by 6.4% in the fourth quarter. Commonwealth Equity Services LLC now owns 13,583 shares of the company valued at $440,000 after buying 817 additional shares in the last quarter. Atlas Capital Advisors LLC increased its stake in Fresenius Medical Care AG & Co. KGaA by 27.1% in the fourth quarter. Atlas Capital Advisors LLC now owns 9,266 shares of the company valued at $301,000 after purchasing an additional 1,973 shares last quarter. UMB Bank NA MO acquired a new stake in Fresenius Medical Care AG & Co. KGaA in the fourth quarter worth $192,000. Cacti Asset Management LLC increased its stake in Fresenius Medical Care AG & Co. KGaA by 35.8% in the first quarter. Cacti Asset Management LLC now owns 36,000 shares of the company valued at $1,212,000 after purchasing an additional 9,500 shares last quarter. Finally, Legacy Wealth Asset Management LLC increased its stake in Fresenius Medical Care AG & Co. KGaA by 283.2% in the fourth quarter. Legacy Wealth Asset Management LLC now owns 36,892 shares of the company valued at $1,198,000 after purchasing an additional 27,264 shares last quarter. 4.73% of the shares are currently held by institutional investors and hedge funds.

About Fresenius Medical Care AG & Co. KGaA

(Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Further reading

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Should you invest $1,000 in Fresenius Medical Care AG & Co. KGaA right now?

Before you consider Fresenius Medical Care AG & Co. KGaA, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes a turn… and Fresenius Medical Care AG & Co. KGaA was not on the list.

While Fresenius Medical Care AG & Co. KGaA currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here

Share.

Comments are closed.